Oncological Outcomes of Breast-Conserving Surgery Versus Mastectomy in Invasive Lobular Breast Cancer: A Single-Center Retrospective Study
Medicina · 28.03.2026 · 62 (4) · 645
DOI: 10.3390/medicina62040645 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medicina, online erschienen am 28.03.2026. Verfasst von Simay Çokgezer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Institute of Oncology, Istanbul University, 34093 Istanbul, Turkey. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Segmental, Carcinoma, Lobular, Mastectomy. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives: Invasive lobular carcinoma (ILC) is a breast cancer subtype with a controversial surgical management due to its diffuse infiltrative growth pattern and increased tendency for multicentricity. This study aimed to compare the effects of breast-conserving surgery (BCS) and mastectomy on long-term overall survival (OS) and progression-free survival (PFS) in patients diagnosed with ILC. Materials and Methods: In this single-center, retrospective, observational study, 255 patients with histopathologically confirmed ILC between 2017 and 2025 were included. Patients who underwent surgical treatment were divided into two groups according to the surgical approach: BCS (n = 94) and mastectomy (n = 141). Survival analyses were performed using the Kaplan–Meier method, and comparisons between groups were assessed with the log-rank test. Factors affecting survival were evaluated using Cox regression analysis.
Results
The median age of the patients was 53 years (range, 28–85), and the median follow-up duration was 31.8 months. Of the cases, 76.9% were classic-type ILC and 70.9% had stage I–II disease. The rate of negative surgical margins was 87.6%. No statistically significant differences were observed between the BCS and mastectomy groups in terms of estimated median PFS (87.4 months vs. 86.7 months; p > 0.05) or estimated median OS (87.7 months vs. 115.7 months; p > 0.05). Multivariable analyses demonstrated that the type of surgery was not an independent prognostic factor for survival.
Conclusions
This study shows that, with appropriate patient selection and adequate surgical margin control, BCS provides oncologic survival outcomes comparable to mastectomy in ILC. The choice of surgical approach should be individualized based on tumor biology, stage, and multidisciplinary evaluation rather than histological subtype alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Institute of Oncology, Istanbul University, 34093 Istanbul, Turkey.
- Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey.
ORCID-Profile: Simay Çokgezer, Aysel Safaraliyeva, Sevde Topuz, Muhammet Şenkal, Naziye Ak
Zitieren
APA
Çokgezer, S., Safaraliyeva, A., Topuz, S., Şenkal, M., Ak, N., Taştekin, D., & Saip, P. M. (2026). Oncological Outcomes of Breast-Conserving Surgery Versus Mastectomy in Invasive Lobular Breast Cancer: A Single-Center Retrospective Study. Medicina, 62(4), 645. https://doi.org/10.3390/medicina62040645
Vancouver
Çokgezer S, Safaraliyeva A, Topuz S, Şenkal M, Ak N, Taştekin D, et al. Oncological Outcomes of Breast-Conserving Surgery Versus Mastectomy in Invasive Lobular Breast Cancer: A Single-Center Retrospective Study. Medicina. 2026;62(4):645. doi:10.3390/medicina62040645
BibTeX
@article{okgezer2026,
author = {Çokgezer, Simay and Safaraliyeva, Aysel and Topuz, Sevde and Şenkal, Muhammet and Ak, Naziye and Taştekin, Didem and Saip, Pınar Mualla},
title = {Oncological Outcomes of Breast-Conserving Surgery Versus Mastectomy in Invasive Lobular Breast Cancer: A Single-Center Retrospective Study},
journal = {Medicina},
year = {2026},
volume = {62},
number = {4},
pages = {645},
doi = {10.3390/medicina62040645}
}
EUVIMED